News

Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...
Tennis World USA on MSN1d
Paolo Bertolucci shuts down Alexander Zverev’s ball fury: 'They were good last year!'
Alexander Zverev's outburst over the balls at the Rome Masters stirred reactions in tennis world. One of the strongest came ...
Posting and Toasting on MSN1d
Knicks Bulletin: ‘Once you have a label, it’s hard to shed that label’
The day has arrived and we’re about to witness the New York Knicks go to war against a bunch of Hicks. In the Eastern ...